A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy

Clinical trial NCT03830281 · COMPLETED

Trial details

NCT number: NCT03830281
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-02-14
Primary completion: 2020-01-06
Enrollment: 471

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.